Britain is poised to miss out on billions in pharmaceutical R&D investment and access to new medicines unless urgent reforms are made to the NHS medicine rebate system, according to
Britain is poised to miss out on billions in pharmaceutical R&D investment and access to new medicines unless urgent reforms are made to the NHS medicine rebate system, according to
Doctors who have trained in Britain will gain priority access to NHS job placements under Labour’s newly proposed ten-year plan to overhaul the health service. Health Secretary Wes Streeting has
Public sector workers in the UK are reacting strongly to the government’s latest pay rise announcements, with unions across various sectors threatening industrial action. Ministers have pledged above-inflation pay increases
The £1.7 billion takeover scramble for Assura, Britain’s prominent primary healthcare property firm, has taken a heated turn. Major UK shareholders have openly rejected an acquisition attempt led by US
The first clinical trial investigating whether psilocybin, the psychedelic compound found in magic mushrooms, could treat Parkinson’s disease has yielded promising early-stage results. Scientists have described the findings as both
Wes Streeting, the Health Secretary, has criticised junior doctors for moving forward with a strike ballot before the government has had the opportunity to present its pay offer. He argued
Cancer experts and health policy analysts have urged the NHS in England to adopt a stronger focus on early intervention to improve cancer survival rates. A recent report by health
Rachel Reeves’s ambitious £100 billion investment initiative, aimed at bolstering public infrastructure and economic growth, is facing criticism for being insufficient to meet the pressing needs of the UK’s public
In a significant move towards modernising cancer diagnostics, the NHS has announced a £2.4 million investment in groundbreaking blood test technology capable of detecting 12 different types of cancer. The
Private clinics delivering NHS cataract surgery are under intense scrutiny amid allegations of artificially inflated costs, unnecessary operations, and questionable financial incentives offered to high-street optometrists. The Department of Health
Research suggests that thousands of lives could be saved and subsequent heart attacks or strokes prevented through the administration of two cost-effective medicines. The study, conducted jointly by Imperial College
British pharmaceutical giant AstraZeneca has secured NHS approval for its groundbreaking breast cancer drug capivasertib, marking a significant milestone in oncology treatment. The twice-daily tablet, developed in Cambridge, demonstrates remarkable
The National Health Service has unveiled a groundbreaking initiative, offering accelerated access to a pioneering cancer vaccine trial. This strategic move demonstrates the UK’s commitment to maintaining its position at
The NHS is embarking on a significant initiative aimed at removing up to 300,000 patients from its waiting lists in an effort to streamline operations and enhance patient care. This
UK Government Accelerates Clinical Trials and Improves Access to NHS Data The United Kingdom government has unveiled ambitious plans aimed at enhancing the speed of clinical trials and facilitating greater
In a groundbreaking initiative aimed at addressing a multitude of social and health-related issues, an ambitious scheme is set to deploy an army of health workers door-to-door across various regions






